[ad_1] Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. …
Tag: Pharmaceuticals
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
[ad_1] George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs…
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
[ad_1] An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s…
Vertex shares pop after nonopioid painkiller posts positive midstage trial results
[ad_1] A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after…
Pfizer shares fall as 2024 revenue and profit forecast disappoints
[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products. Pfizer also…
It’s Biotech Stocks’ Time to Shine
[ad_1] These are hard times for the biotech sector. Barely a day goes by without layoffs being announced somewhere in Boston or California, and there are still more than 100…
AstraZeneca to Buy Icosavax for Up to $1.1 Bln
[ad_1] AstraZeneca said it would buy U.S.-based clinical-stage biopharmaceutical company Icosavax for up to $1.1 billion in a deal that expands its vaccines and immune therapies late-stage pipeline. The pharmaceutical…
Pfizer Warns 2024 Revenue Could Fall, Weighed Down by Soft Demand for Covid Products
[ad_1] Updated Dec. 13, 2023 10:16 am ET Pfizer shares tumbled Wednesday morning after the company said revenue could fall next year and issued 2024 guidance below analyst expectations. Shares…